Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- NHS England · Body governed by public law
- Suppliers
- Roche Products Ltd, Sandoz Ltd SME, Eli Lilly and Company Ltd, Chugai Pharma UK Ltd SME, Mylan SME, Aventis Pharma Ltd Trading As Sanofi, Manx Healthcare Ltd SME, Janssen-Cilag Ltd, Novo Nordisk, Sun Pharma UK Ltd, Merck Serono Limited, Amgen Ltd +16 more
- Value
- £29 across 29 lots
- Procedure
- Open procedure
- Sector
- Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
- Region
- London
- Official notice
- 042580-2025 on Find a Tender
- Timeline
-
- Contract date25 Jun 2025
- Published24 Jul 2025Published 29 days after the contract date
Description
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025<br/>CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027<br/>CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines – Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026
Lots in this award
| Lot | Supplier | Value |
|---|---|---|
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Roche Products Ltd | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Sandoz Ltd SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Eli Lilly and Company Ltd | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Chugai Pharma UK Ltd SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Mylan SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Aventis Pharma Ltd Trading As Sanofi | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Manx Healthcare Ltd SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Janssen-Cilag Ltd | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Novo Nordisk | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Sun Pharma UK Ltd | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Merck Serono Limited | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Amgen Ltd | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Bayer Plc | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Napp Pharmaceuticals Ltd SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | AstraZeneca | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | CST Pharma Ltd | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Pharmacosmos UK Ltd SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Thornton & Ross SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | GlaxoSmithKline UK Limited | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Gedeon Richter UK Ltd SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Seqirus UK Limited | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Aventis Pharma Ltd Trading As Sanofi | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Biogen | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Teva UK Limited | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Dr Reddy's Laboratories (UK) Ltd SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Orifarm UK | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Pfizer Ltd | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Vifor Pharma UK Ltd SME | £1 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | Accord-UK Ltd SME | £1 |
About the suppliers
Roche Products Ltd: every public contract they have won, plus their Companies House record (company 04369760).
Amgen Ltd: every public contract they have won.
Biogen: every public contract they have won, plus their Companies House record (company 01497267).
Teva UK Limited: every public contract they have won, plus their Companies House record (company 00302461).
Dr Reddy's Laboratories (UK) Ltd: every public contract they have won, plus their Companies House record (company 01729064).
Orifarm UK: every public contract they have won, plus their Companies House record (company 10015046).
Pfizer Ltd: every public contract they have won, plus their Companies House record (company 00526209).
Vifor Pharma UK Ltd: every public contract they have won, plus their Companies House record (company 06514784).
Accord-UK Ltd: every public contract they have won, plus their Companies House record (company 00079585).
Sandoz Ltd: every public contract they have won, plus their Companies House record (company 01547204).
Eli Lilly and Company Ltd: every public contract they have won, plus their Companies House record (company 00284385).
Chugai Pharma UK Ltd: every public contract they have won, plus their Companies House record (company 02814621).
Mylan: every public contract they have won, plus their Companies House record (company 09189103).
Aventis Pharma Ltd Trading As Sanofi: every public contract they have won, plus their Companies House record (company 01535640).
Manx Healthcare Ltd: every public contract they have won.
Janssen-Cilag Ltd: every public contract they have won, plus their Companies House record (company 01027904).
Novo Nordisk: every public contract they have won, plus their Companies House record (company 01118740).
Sun Pharma UK Ltd: every public contract they have won, plus their Companies House record (company 02992795).
Merck Serono Limited: every public contract they have won, plus their Companies House record (company 00990823).
Bayer Plc: every public contract they have won, plus their Companies House record (company 00935048).
Napp Pharmaceuticals Ltd: every public contract they have won, plus their Companies House record (company 03690299).
AstraZeneca: every public contract they have won, plus their Companies House record (company 03674842).
CST Pharma Ltd: every public contract they have won, plus their Companies House record (company 04212740).
Pharmacosmos UK Ltd: every public contract they have won, plus their Companies House record (company 03104505).
Thornton & Ross: every public contract they have won, plus their Companies House record (company 00185947).
GlaxoSmithKline UK Limited: every public contract they have won, plus their Companies House record (company 04310159).
Gedeon Richter UK Ltd: every public contract they have won, plus their Companies House record (company 04325685).
Seqirus UK Limited: every public contract they have won.